350 related articles for article (PubMed ID: 33321951)
1. Potential of the Electronic Nose for the Detection of Respiratory Diseases with and without Infection.
Licht JC; Grasemann H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321951
[TBL] [Abstract][Full Text] [Related]
2. Electronic Nose Technology in Respiratory Diseases.
Dragonieri S; Pennazza G; Carratu P; Resta O
Lung; 2017 Apr; 195(2):157-165. PubMed ID: 28238110
[TBL] [Abstract][Full Text] [Related]
3. Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
Rocco G
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2622-2625. PubMed ID: 29602425
[No Abstract] [Full Text] [Related]
4. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
[TBL] [Abstract][Full Text] [Related]
6. Breathprinting and Early Diagnosis of Lung Cancer.
Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R
J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822
[TBL] [Abstract][Full Text] [Related]
7. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.
Principe S; van Bragt JJMH; Longo C; de Vries R; Sterk PJ; Scichilone N; Vijverberg SJH; Maitland-van der Zee AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806279
[TBL] [Abstract][Full Text] [Related]
9. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
10. Electronic nose in discrimination of children with uncontrolled asthma.
Tenero L; Sandri M; Piazza M; Paiola G; Zaffanello M; Piacentini G
J Breath Res; 2020 Jul; 14(4):046003. PubMed ID: 32512553
[TBL] [Abstract][Full Text] [Related]
11. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
12. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
[TBL] [Abstract][Full Text] [Related]
13. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
[TBL] [Abstract][Full Text] [Related]
14. A review on electronic nose for diagnosis and monitoring treatment response in lung cancer.
Vadala R; Pattnaik B; Bangaru S; Rai D; Tak J; Kashyap S; Verma U; Yadav G; Dhaliwal RS; Mittal S; Hadda V; Madan K; Guleria R; Agrawal A; Mohan A
J Breath Res; 2023 Mar; 17(2):. PubMed ID: 36720157
[TBL] [Abstract][Full Text] [Related]
15. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
[TBL] [Abstract][Full Text] [Related]
16. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions.
Fens N; van der Schee MP; Brinkman P; Sterk PJ
Clin Exp Allergy; 2013 Jul; 43(7):705-15. PubMed ID: 23786277
[TBL] [Abstract][Full Text] [Related]
18. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
[TBL] [Abstract][Full Text] [Related]
19. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
20. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
